Symposium - European Medical Journal

Continue

Symposiums

Respiratory
10 Mins
1 Nov 2018

Focussing on The Patient: Future Prospects in Alpha 1 Management

With new patient-centric and scientific networks being created, Prof Chorostowska-Wynimko explored how these initiatives, such as the European Alpha-1…
Respiratory
7 Mins
1 Nov 2018

Back to Basics in Asthma and COPD: Optimising the Patient Journey

The objective of this symposium was to build on the guiding principles of asthma and chronic obstructive pulmonary disease (COPD) and to address some…
Respiratory
8 Mins
1 Nov 2018

State-of-the-Art Session: Respiratory Infections

In recent decades, there has been growing interest in the recognition and management of both bronchiectasis and nontuberculous mycobacteria (NTM)…
Respiratory
8 Mins
1 Nov 2018

Discovering Asthma Paradigms in an Evolving Landscape: Expert Perspectives

This symposium took place during the 2018 European Respiratory Society (ERS) International Congress in Paris, France and focussed on the disease burden…
Dermatology
10 Mins
30 Oct 2018

PASI 90/100, DLQI 0/1, and IL-17 Receptor/Cytokine: Does it Make a Difference and Are We Ambitious Enough?

The main objectives of the symposium were to review recent evidence on what difference targeting Psoriasis Area Severity Index (PASI) 90 or 100 and…
Dermatology
9 Mins
30 Oct 2018

Navigating the Road to Psoriasis Control in Women: Strategies to Optimise the Reproductive Journey

The importance of discussions around the management of women of childbearing age with psoriasis, an issue that has been largely neglected for many years…
Dermatology
10 Mins
30 Oct 2018

Is Complete Skin Clearance in Psoriasis the Answer?

Prof Reich outlined the new understanding of psoriasis pathogenesis, with IL-23 rather than IL-12 considered the pivotal cytokine pathway. This…
Dermatology
9 Mins
30 Oct 2018

IL-23 Inhibition in Psoriasis: Changing the Present, Shaping the Future

This symposium took place at the 27th European Academy of Dermatology and Venereology (EADV) Congress. The session examined the latest data for…